When the Game Changes Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic

Sweiss, Nadera J; Korsten, Peter; Syed, Huzaefah J; Syed, Aamer; Baughman, Robert P; Yee, Arthur MF; Culver, Daniel A; Sosenko, Teresa; Azuma, Arata; Bonella, Francesco; Costabel, Ulrich; Drake, Wonder P; Drent, Marjolein; Lower, Elyse E; Israel-Biet, Dominique; Mostard, Remy LM; Nunes, Hilario; Rottoli, Paola; Spagnolo, Paolo; Wells, Athol U; Wuyts, Wim A; Judson, Marc A

doi:10.1016/j.chest.2020.04.033

When the Game Changes Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic

Author:

Sweiss, Nadera J

Korsten, Peter ; Syed, Huzaefah J ; Syed, Aamer ; Baughman, Robert P ; Yee, Arthur MF ; Culver, Daniel A ; Sosenko, Teresa ; Azuma, Arata ; Bonella, Francesco ; Costabel, Ulrich ; Drake, Wonder P ; Drent, Marjolein ; Lower, Elyse E ; Israel-Biet, Dominique ; Mostard, Remy LM ; Nunes, Hilario ; Rottoli, Paola ; Spagnolo, Paolo ; Wells, Athol U ; Wuyts, Wim A ; Judson, Marc A

Keywords:

Science & Technology, Life Sciences & Biomedicine, Critical Care Medicine, Respiratory System, General & Internal Medicine, coronavirus disease, diffuse lung disease, immunosuppressives, sarcoidosis, SARS, severe acute respiratory syndrome, RHEUMATOID-ARTHRITIS, INFECTION, EFFICACY, THERAPY, ADA, adalimumab, COVID-19, coronavirus disease 2019, DMASD, disease-modifying antisarcoid drug, GC, glucocorticoid, Betacoronavirus, COVID-19, Coronavirus Infections, Disease Management, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2, Sarcoidosis, 1103 Clinical Sciences, 3201 Cardiovascular medicine and haematology, 3202 Clinical sciences